BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23326393)

  • 21. Dynein Light Chain 1 (DYNLT1) Interacts with Normal and Oncogenic Nucleoporins.
    Sarma NJ; Yaseen NR
    PLoS One; 2013; 8(6):e67032. PubMed ID: 23840580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice.
    Kroon E; Thorsteinsdottir U; Mayotte N; Nakamura T; Sauvageau G
    EMBO J; 2001 Feb; 20(3):350-61. PubMed ID: 11157742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergy of NUP98-HOXA10 Fusion Gene and NrasG12D Mutation Preserves the Stemness of Hematopoietic Stem Cells on Culture Condition.
    Dong Y; Xia C; Weng Q; Wang T; Hu F; Wang K; Liu X; Geng Y; Liu L; Wu H; Du J
    Cells; 2019 Aug; 8(9):. PubMed ID: 31443434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of cooperative genes for NUP98-HOXA9 in myeloid leukemogenesis using a mouse model.
    Iwasaki M; Kuwata T; Yamazaki Y; Jenkins NA; Copeland NG; Osato M; Ito Y; Kroon E; Sauvageau G; Nakamura T
    Blood; 2005 Jan; 105(2):784-93. PubMed ID: 15454493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cell-cycle regulator geminin inhibits Hox function through direct and polycomb-mediated interactions.
    Luo L; Yang X; Takihara Y; Knoetgen H; Kessel M
    Nature; 2004 Feb; 427(6976):749-53. PubMed ID: 14973489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Identification of proteins associated with transcription factors HOXA9 and E2A-PBX1 by tandem affinity purification].
    Shestakova EA; Boutin M; Bourassa S; Bonneil E; Bijl JJ
    Mol Biol (Mosk); 2017; 51(3):490-501. PubMed ID: 28707666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HOXA9 promotes hematopoietic commitment of human embryonic stem cells.
    Ramos-Mejía V; Navarro-Montero O; Ayllón V; Bueno C; Romero T; Real PJ; Menendez P
    Blood; 2014 Nov; 124(20):3065-75. PubMed ID: 25185710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NUP98 dysregulation in myeloid leukemogenesis.
    Moore MA; Chung KY; Plasilova M; Schuringa JJ; Shieh JH; Zhou P; Morrone G
    Ann N Y Acad Sci; 2007 Jun; 1106():114-42. PubMed ID: 17442773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pbx3 and Meis1 cooperate through multiple mechanisms to support Hox-induced murine leukemia.
    Garcia-Cuellar MP; Steger J; Füller E; Hetzner K; Slany RK
    Haematologica; 2015 Jul; 100(7):905-13. PubMed ID: 25911551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of HOXA10 perturbs human lymphomyelopoiesis in vitro and in vivo.
    Buske C; Feuring-Buske M; Antonchuk J; Rosten P; Hogge DE; Eaves CJ; Humphries RK
    Blood; 2001 Apr; 97(8):2286-92. PubMed ID: 11290589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NUP98 fusion in human leukemia: dysregulation of the nuclear pore and homeodomain proteins.
    Nakamura T
    Int J Hematol; 2005 Jul; 82(1):21-7. PubMed ID: 16105755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Geminin deletion from hematopoietic cells causes anemia and thrombocytosis in mice.
    Shinnick KM; Eklund EA; McGarry TJ
    J Clin Invest; 2010 Dec; 120(12):4303-15. PubMed ID: 21041951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smad4 binds Hoxa9 in the cytoplasm and protects primitive hematopoietic cells against nuclear activation by Hoxa9 and leukemia transformation.
    Quéré R; Karlsson G; Hertwig F; Rissler M; Lindqvist B; Fioretos T; Vandenberghe P; Slovak ML; Cammenga J; Karlsson S
    Blood; 2011 Jun; 117(22):5918-30. PubMed ID: 21471525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Geminin in cell fate determination of hematopoietic stem cells (HSCs).
    Yasunaga S; Ohno Y; Shirasu N; Zhang B; Suzuki-Takedachi K; Ohtsubo M; Takihara Y
    Int J Hematol; 2016 Sep; 104(3):324-9. PubMed ID: 27422432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity.
    Kasper LH; Brindle PK; Schnabel CA; Pritchard CE; Cleary ML; van Deursen JM
    Mol Cell Biol; 1999 Jan; 19(1):764-76. PubMed ID: 9858599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.
    Wang GG; Cai L; Pasillas MP; Kamps MP
    Nat Cell Biol; 2007 Jul; 9(7):804-12. PubMed ID: 17589499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TGFbeta/BMP inhibits the bone marrow transformation capability of Hoxa9 by repressing its DNA-binding ability.
    Wang N; Kim HG; Cotta CV; Wan M; Tang Y; Klug CA; Cao X
    EMBO J; 2006 Apr; 25(7):1469-80. PubMed ID: 16525506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. X-linked intellectual disability gene CUL4B targets Jab1/CSN5 for degradation and regulates bone morphogenetic protein signaling.
    He F; Lu D; Jiang B; Wang Y; Liu Q; Liu Q; Shao C; Li X; Gong Y
    Biochim Biophys Acta; 2013 May; 1832(5):595-605. PubMed ID: 23357576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNA export factor RAE1 contributes to NUP98-HOXA9-mediated leukemogenesis.
    Funasaka T; Nakano H; Wu Y; Hashizume C; Gu L; Nakamura T; Wang W; Zhou P; Moore MA; Sato H; Wong RW
    Cell Cycle; 2011 May; 10(9):1456-67. PubMed ID: 21467841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion.
    Thorsteinsdottir U; Mamo A; Kroon E; Jerome L; Bijl J; Lawrence HJ; Humphries K; Sauvageau G
    Blood; 2002 Jan; 99(1):121-9. PubMed ID: 11756161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.